Skip to content

Alveolar Ridge Preservation Using Collagen Material and Allograft

Alveolar Ridge Preservation Using Collagen Material and Allograft: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04321109
Enrollment
14
Registered
2020-03-25
Start date
2016-06-02
Completion date
2018-03-21
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Ridge Preservation

Keywords

Alveolar ridge preservation, Allograft, Collagen cone

Brief summary

Seven Patients who need implants to replace non-restorable teeth in the esthetic zone. Intervention Group (1): Seven extraction sockets that received the collagen matrix (Collagen cone) for alveolar ridge preservation. Comparison Group (2): Seven extraction sockets that were treated with mineralized cortico-cancellous bone allograft for alveolar ridge preservation. Outcome 1. Alveolar ridge preservation both in height and in width to improve implant success rate * The height of alveolar ridge was assessed clinically using a periodontal probe. * The width of the alveolar ridge was measured after three months after extraction using a caliper clamp. * Changes in the width and height of alveolar bone were evaluated in merged axial and sagittal views using the I-CAT superimposition system (CBCT). 2- Evaluation of newly formed bone quality was performed by histological examination and histomorphometric analysis. 3- Immuno-histochemical staining was done using polyclonal antibody to detect (BMP-2) marker of bone formation

Detailed description

The aim of the present study was to compare three months post-extraction augmented ridge using collagen matrix versus mineralized cortico-cancellous bone allograft. This comparison was done clinically, histologically, immunohisto-chemically and radiologically. • Clinical parameters included; vertical bone height and bone width that were recorded at baseline and at three months after extraction. Moreover, histomorphometric parameters included; area fraction of osteoid and mature bone three months after extraction by histomorphometric analysis. Immunohistochemical analysis using polyclonal antibody to detect BMP-2 marker of bone formation. Radiographic parameters included superimposition of baseline CBCT, three months after extraction and another one six months after loading with subsequent measurement of bone height, bone width and bone density. A core biopsy was taken three months after tooth extraction which has undergone histomorphometric and immunohistochemical analysis; implant placement was also done at the same time. In the present study, it was found that the mean bone height decreased with a higher percent in collagen matrix group than mineralized cortico-cancellous bone allograft group with a non significant difference between both groups. In addition, this study showed that the mean bone width decreased more in collagen matrix group than mineralized cortico-cancellous bone allograft group with a non significant difference between them. Moreover, in the present study, Histomorphometric analysis revealed new bone trabeculae formation with osteoblastic rimming, the surrounding fibrous tissue is cellular and remnants of the graft materials was detected , with no marked difference in the amount of newly formed bone between two groups . Regarding immunohistochemical analysis in both groups, the osteoblasts in the fibrous tissue and osteocytes in newly formed bone are showing nuclear staining, with increasing area of immunopositive cells in mineralized cortico-cancellous bone allograft group. Radiographically, CBCT superimposition revealed that a greater percent decrease in bone height was denoted in collagen matrix than mineralized cortico-cancellous bone allograft group with a significant difference between both groups after 3 and 6 months. Accordingly bone width showed a higher decrease in mineralized cortico-cancellous bone allograft group than Collagen matrix group with a non significant difference between both groups after 3 and 6 months. Finally, bone density showed a greater decrease in Collagen matrix group than mineralized cortico-cancellous bone allograft group with a non significant difference after 3 months but significant difference was found after 6 months between both groups.

Interventions

OTHERAllograft

Corticocancellous mineralized allograft

OTHERCollagen cone

Collagen matrix

Sponsors

Yasmine Fouad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Results were sent to Outcome Assessor masked , so he was not able to know results belong to which group

Intervention model description

Group (1): Seven extraction sockets that received the collagen matrix (Collacone) for alveolar ridge preservation. Group (2): Seven extraction sockets that were treated with mineralized cortico-cancellous bone allograft (Maxgraft) for alveolar ridge preservation

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1. Patients were medically free . 2. Two teeth indicated for extraction due to either severe decay, tooth fracture or failed endodontic treatment.

Exclusion criteria

1. Patients with poor oral hygiene or not willing to perform oral hygiene measures. 2. Pregnant and breast-feeding females. 3. Smokers , Teeth with periodontal or periapical infections. 4. Patients with malocclusion. 5. All patients who had known contraindication to dental implant surgery (e.g: bleeding tendency, radiotherapy, taking bisphosphonate)

Design outcomes

Primary

MeasureTime frameDescription
clinical scorechange from baseline at 12 weeksDimensional changes in alveolar ridge after alveolar ridge preservation both clinically and radiographically

Secondary

MeasureTime frameDescription
BMP-2detected at 12 weeksBone morphogenic protein -2 immunopositive cells in immunostained sections

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026